Showing results (31-40 of 172) with videos related to
Sort By:
Pageof 18
Neurotoxicology|June 10, 2024
Neurotoxicology of dopamine: Victim or assailant?Meghan L Bucher, Jocelyn Dicent, Carolina Duarte Hospital, et al.Neurotoxicology|November 14, 2002
Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cellsStacy E Stephans, Gary W Miller, Allan I Levey, et al.Neuroscience Letters|April 11, 2006
Use-dependent behavioral and neurochemical asymmetry in MPTP miceW Michael Caudle, Jennifer L Tillerson, María E Reverón, et al.Experimental Neurology|December 4, 2002
Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineJennifer L Tillerson, W Michael Caudle, Maria E Reverón, et al.Current Neurology and Neuroscience Reports|May 22, 2013
Vesicular integrity in Parkinson's diseaseShawn P Alter, Gina M Lenzi, Alison I Bernstein, et al.Trends in Neurosciences|May 13, 2008
Altered vesicular dopamine storage in Parkinson's disease: a premature demiseW Michael Caudle, Rebecca E Colebrooke, Piers C Emson, et al.Environmental Health Perspectives|September 4, 2024
Seminar: Functional Exposomics and Mechanisms of Toxicity-Insights from Model Systems and NAMsYunjia Lai, Muhammet Ay, Carolina Duarte Hospital, et al.Neurotoxicology|February 8, 2012
Industrial toxicants and Parkinson's diseaseW Michael Caudle, Thomas S Guillot, Carlos R Lazo, et al.Science Signaling|January 21, 2025
Biotin mitigates the development of manganese-induced, Parkinson's disease-related neurotoxicity in Drosophila and human neuronsYunjia Lai, Pablo Reina-Gonzalez, Gali Maor, et al.Biorxiv : the Preprint Server for Biology|December 4, 2023
Biotin rescues manganese-induced Parkinson's disease phenotypes and neurotoxicityYunjia Lai, Pablo Reina-Gonzalez, Gali Maor, et al.Pageof 18